Litcius/Paper detail

Pembrolizumab as a first-line treatment for advanced gastric cancer

Ian Chau

2023The Lancet Oncology10 citationsDOI

Topics & Concepts

PembrolizumabMedicineNivolumabInternal medicineChemotherapyCancerAdenocarcinomaOncologyClinical trialIpilimumabGastroesophageal JunctionGastroenterologyImmunotherapyGastric Cancer Management and OutcomesGastrointestinal Tumor Research and TreatmentPancreatic and Hepatic Oncology Research
Pembrolizumab as a first-line treatment for advanced gastric cancer | Litcius